Gene · 1420
Papers1,603
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,603
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Obesogens in Prostate Cancer: An Endocrine and Metabolic Threat. | Curr Obes Rep | 2026 | 41739363 | PubTator, text mining | PubMed |
| Temporal dynamics in cancer immunotherapy: the interplay between circadian rhythms, tumor microenvironment, and immune checkpoint blockade. | J Natl Cancer Cent | 2026 | 41738042 | PubTator, text mining | PubMed |
| Impact of nutrition on long COVID. | Sports Med Health Sci | 2026 | 41737593 | PubTator, text mining | PubMed |
| Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis. | World Allergy Organ J | 2026 | 41732343 | PubTator, text mining | PubMed |
| Single-cell immunophenotyping identifies CD8+GZMK+IFNG+ T cells as a key immune population in cutaneous Lyme disease. | JCI Insight | 2026 | 41729083 | PubTator, text mining | PubMed |
| Effects of T2-high asthma heterogeneity and inhaled corticosteroid on airway and metabolic profiles: A multi-omic approach. | J Transl Int Med | 2026 | 41727967 | PubTator, text mining | PubMed |
| Role of trained immunity in DCs and macrophages in the induction of Th2 responses and allergy treatment. What do we know? | Front Immunol | 2026 | 41727488 | PubTator, text mining | PubMed |
| ENPP3 drives ccRCC progression by cGAMP hydrolysis and STING-IFN suppression. | Cancer Biol Ther | 2026 | 41715305 | PubTator, text mining | PubMed |
| Life-Threatening SARS-CoV-2-Associated Encephalopathy and Multiorgan Failure in Children, Asia and Oceania, 2022-2024. | Emerg Infect Dis | 2026 | 41714597 | PubTator, text mining | PubMed |
| CCR-CCL axes as key upstream influencers of pancreatic ductal adenocarcinoma: CCR2-CCL2, CCR5-CCL5, CCR4-CCL17/22, CCR6-CCL20, CCR7-CCL19/21. | Front Immunol | 2026 | 41694374 | PubTator, text mining | PubMed |
| Nanoparticle approaches for hepatitis therapy and clinical translation. | Discov Nano | 2026 | 41649705 | PubTator, text mining | PubMed |
| Single-cell transcriptomics and machine-learning reveal M1 macrophage-driven progression from minimal change disease to focal segmental glomerulosclerosis. | Ren Fail | 2026 | 41622775 | PubTator, text mining | PubMed |
| Preventing surgery-induced natural killer cell suppression and metastases by inhibiting PI3K-gamma signaling in myeloid-derived suppressor cells. | J Immunother Cancer | 2026 | 41611243 | PubTator, text mining | PubMed |
| EBV Dysregulation Is Associated With Immune Imbalance in Multiple Sclerosis: Evidence From Integrated Viral and Host Analyses. | Neurol Neuroimmunol Neuroinflamm | 2026 | 41610382 | PubTator, text mining | PubMed |
| CXCR4-modification enhances CAR-T efficacy by improving tumor tracking and bone marrow homing in B-cell malignancies. | Signal Transduct Target Ther | 2026 | 41605906 | PubTator, text mining | PubMed |
| Targeting AKR1B1 reprograms tumor-associated macrophages to enhance antitumor immunity. | J Immunother Cancer | 2026 | 41592892 | PubTator, text mining | PubMed |
| Phase 1b/2 study of BMS-813160, a CCR2/5 dual antagonist, in combination with chemotherapy or nivolumab in patients with advanced pancreatic or colorectal cancer. | J Immunother Cancer | 2026 | 41571299 | PubTator, text mining | PubMed |
| <p>Converting 'cold' to 'hot' hepatocellular carcinoma for improved immunotherapy (Review)</p>. | Mol Med Rep | 2026 | 41543193 | PubTator, text mining | PubMed |
| <p>Regulatory networks of HIFs in tumor‑infiltrating immune cells: From molecular mechanisms to therapeutic implications (Review)</p>. | Int J Oncol | 2026 | 41543185 | PubTator, text mining | PubMed |
| Proteotranscriptomic Dissection of Breast Cancer T Cell States Identifies CD103+ Tfh-derived Cytotoxic Cells Linked to Immunotherapy Response. | Res Sq | 2026 | 41542042 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1420/papers?page=2